<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T01:44:34Z</responseDate>
  <request identifier="oai:figshare.com:article/34047649" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34047649</identifier>
        <datestamp>2026-10-01T17:26:17Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Histopathological effects of different doses of crocin and orlistat on liver tissue in the studied groups, based on H&amp;E staining (400×).&lt;/p&gt;</dc:title>
          <dc:creator>Hossain Rezayee (25157659)</dc:creator>
          <dc:creator>Mohammad Ali Fahmidehkar (25157662)</dc:creator>
          <dc:creator>Farimah Beheshti (4791291)</dc:creator>
          <dc:creator>Mohsen Ghoryani (25157665)</dc:creator>
          <dc:creator>Yaser Yousefpoor (25157668)</dc:creator>
          <dc:creator>Dawood Hossaini (25157671)</dc:creator>
          <dc:creator>Davod Ilbeigi (25157674)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>containing seven rats</dc:subject>
          <dc:subject>confirmed marked improvement</dc:subject>
          <dc:subject>alkaline phosphatase levels</dc:subject>
          <dc:subject>increased hepatic malondialdehyde</dc:subject>
          <dc:subject>xlink "&gt; forty</dc:subject>
          <dc:subject>present study demonstrate</dc:subject>
          <dc:subject>liver function enzymes</dc:subject>
          <dc:subject>hepatic structural alterations</dc:subject>
          <dc:subject>hepatic lipid accumulation</dc:subject>
          <dc:subject>oxidative stress biomarkers</dc:subject>
          <dc:subject>serum lipid profiles</dc:subject>
          <dc:subject>xlink "&gt; non</dc:subject>
          <dc:subject>xlink "&gt; high</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>oxidative stress</dc:subject>
          <dc:subject>hepatic steatosis</dc:subject>
          <dc:subject>study aims</dc:subject>
          <dc:subject>lipid profile</dc:subject>
          <dc:subject>histopathological alterations</dc:subject>
          <dc:subject>fatty liver</dc:subject>
          <dc:subject>therapeutic agent</dc:subject>
          <dc:subject>rat model</dc:subject>
          <dc:subject>nitrite concentrations</dc:subject>
          <dc:subject>inflammatory infiltration</dc:subject>
          <dc:subject>histopathological evaluation</dc:subject>
          <dc:subject>four weeks</dc:subject>
          <dc:subject>eight weeks</dc:subject>
          <dc:subject>antioxidant status</dc:subject>
          <dc:subject>animal model</dc:subject>
          <dc:subject>alanine aminotransferase</dc:subject>
          <dc:description>&lt;p&gt;Experimental groups (n = 7 per group) were defined as follows: ND, normal diet (control group); HFD, high-fat diet (Fat) group; Cr10, Cr30, and Cr50, animals receiving crocin at doses of 10, 30, and 50 mg/kg body weight, respectively; Orl, animals treated with orlistat. Representative H&amp;E-stained liver sections are shown for: A: normal diet; B, B1: HFD; C, C1: HFD + crocin 10 mg/kg; D: HFD + crocin 30 mg/kg; E: HFD + crocin 50 mg/kg and F: HFD + orlistat 10 mg/kg. Arrows in images B, C, and D indicate hepatocellular ballooning (foam cells), while arrows in images B1 and C1 highlight lymphocyte infiltration (inflammation).&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T17:26:12Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0357768.g004</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Histopathological_effects_of_different_doses_of_crocin_and_orlistat_on_liver_tissue_in_the_studied_groups_based_on_H_E_staining_400_p_/34047649</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
